Financials in USD. Standardized financial statements.
A compact view of how RaySearch Laboratories AB (publ) turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.34B | $1.19B | $1.02B | $843.65M | $641.67M | $651.61M | $741.58M | $627.22M | $585.09M | $531.47M |
| Revenue Growth? | +12.8% | +16.6% | +21.2% | +31.5% | -1.5% | -12.1% | +18.2% | +7.2% | +10.1% | 0.0% |
| Cost of Revenue? | $101.90M | $99.49M | $106.58M | $94.99M | $50.40M | $43.37M | $72.36M | $56.02M | $36.65M | $26.87M |
| Gross Profit? | $1.24B | $1.09B | $915.58M | $748.66M | $591.28M | $608.24M | $669.22M | $571.20M | $548.44M | $504.60M |
| Gross Margin? | +92.4% | +91.7% | +89.6% | +88.7% | +92.1% | +93.3% | +90.2% | +91.1% | +93.7% | +94.9% |
| Operating Expenses? | $950.10M | $832.04M | $800.70M | $718.35M | $655.32M | $611.70M | $620.23M | $501.58M | $372.40M | $316.34M |
| Operating Income? | $292.30M | $260.49M | $114.88M | $42.74M | -$52.64M | -$3.47M | $68.17M | $69.61M | $159.67M | $199.56M |
| EBITDA? | $292.40M | $571.23M | $405.93M | $340.85M | $197.36M | $75.82M | $138.31M | $112.97M | $230.83M | $266.93M |
| Income Before Tax | $287.80M | $262.87M | $110.09M | $32.38M | -$58.67M | -$6.48M | $62.61M | $90.76M | $155.90M | $198.09M |
| Income Tax Expense | $60.00M | $59.35M | $28.52M | $8.60M | -$11.36M | $2.60M | $12.20M | $12.24M | $38.27M | $46.68M |
| Net Income? | $227.80M | $203.51M | $81.57M | $23.78M | -$47.31M | -$9.08M | $50.41M | $78.52M | $117.63M | $151.41M |
| EPS? | $6.65 | $5.94 | $2.38 | $0.69 | $-1.38 | $-0.26 | $1.47 | $2.29 | $3.43 | $4.42 |
| Diluted EPS? | $6.65 | $5.94 | $2.38 | $0.69 | $-1.38 | $-0.26 | $1.47 | $2.29 | $3.43 | $4.42 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality